Centre allocates Rs 267.35 crores to Kerala for Covid response
Rs one crore for each district to create medicine pool and support Centre of Excellence for Telemedicine
Rs one crore for each district to create medicine pool and support Centre of Excellence for Telemedicine
Domestic market and developing countries will need doses of Indian vaccines
This therapy may provide the first potential oral treatment for COVID-19, recognizing the global emergency of new SARS-CoV-2 variants
The company has also applied to DCGI for Emergency Use Authorization (EUA) for ZyCoVD, the world's first Plasmid DNA Vaccine
Company working on COVID vaccine INO 4800
Deal signed with AOP Orphan for US commercial rights
The Phase III clinical trial for NONS is expected to be completed by Q4 2021.
ADG20, a novel monoclonal antibody targeting the spike protein of SARS-CoV-2 and related coronaviruses
2DG has been given emergency approval by the Drug Controller General of India (DCGI) for use on COVID-19 patients in the country
Subscribe To Our Newsletter & Stay Updated